* 1. Personal Information

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The Society of Thoracic Surgeons and General Thoracic Surgical Club.  The Society of Thoracic Surgeons is accredited by the ACCME to provide continuing medical education for physicians.
The Society of Thoracic Surgeons designates this live activity for a maximum of 13.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

* 2. Thursday, March 8:

* 3. Friday, March 9:

* 4. Saturday, March 9:

* 5. Total Credits Claimed

* 6. Overall, how would you rate this educational activity?

* 7. Program topics and content met the stated objectives

* 8. Content was relevant to my educational needs

* 9. Educational format was conducive to learning

* 10. Acquired knowledge will be applied to my practice environment

* 11. I will seek additional information on this subject

Please rate/comment each of the following presentations you attended:
Thursday, March 8, 2018

* 12. Focused Review of Cooperative Group Trials with Thoracic Surgery Involvement
Dennis Wigle

* 13. CALGB 140503
Dennis Wigle

Dennis Wigle

* 15. SWOG

* 16. NCIC
Gail Darling

* 17. RTOG 1010
Linda Martin

* 18. Varencicline Pre-Surgery
Dennis Wigle/Linda Martin

* 19. Pre-Op Rehabilitation 
Dennis Wigle/Linda Martin

* 20. Stage IIIA Update
Linda Martin

* 21. Esophageal Cancer Studies
Linda Martin

* 22. Other Concepts/Novel Trial Ideas

* 23. Update on General Thoracic Surgery Trials Network Development

* 24. Trials Network Concepts
Summery/Review of Empty Spaces

Friday, March 9, 2018

* 25. Bronchoscopic Techniques for Lung Cancer Diagnosis and Treatment
Kazuhiro Yasufuku, M.D., Toronto ON

* 26. The Use of Free DNA Analysis for Lung Cancer
Adrian Sacher, M.D., Toronto ON

* 27. The Society of Thoracic Surgeons Update
Keith Naunhiem. M.D., St. Louis MO

* 28. Robots I
Kazuhiro Yasufuku, M.D., Toronto ON

* 29. Robots II
Robert Cerfolio, M.D., New York NY

* 30. Initiating an Enhanced Recovery Program
Linda Martin, M.D., Charlottesville VA

* 31. The Opioid Crisis - What Can Thoracic Surgeons Do?
Elizabeth Habermann, Ph.D, Rochester MN


* 33. Movie Night

Saturday, March 10, 2018

* 34. Results of Low Dose CT Lung Cancer Screening at a Non-University Tertiary Hospital
John Handy, M.D., Portland OR

* 35. Assessing Unplanned Healthcare Encounters following Resection for Non-Small Cell Lung Cancer (NSCLC):  Should We Be More Proactive?
Trevor Davis, M.D., Baltimore MD

* 36. The New Lung Cancer Staging System
Frank Detterbeck, M.D., New Haven CT 

* 37. The New Esophageal Cancer Staging System
Wayne Hofstetter, M.D., Houston TX

* 38. Novel Therapies for Thoracic Malignancies
Adrian Sacher, M.D., Toronto ON

* 39. Flipping the Classroom
Ara Vaporciyan, M.D., Houston TX

* 40. Peer to Patient Program for Esophageal Cancer
Bart Frazzitta, Monroe Township, NJ

* 41. Update on ABTS MOC
Bryan Meyers, M.D., St. Louis MO


* 43. Super Bowl of X-Rays
Richard Freeman, Indianapolis IN
Linda Martin, Charlottesville VA
John Mitchell, Denver CO


Background Information

* 45. What was your registration category at this meeting?

* 46. Are you actively using and submitting data to The Society of Thoracic Surgeons General Thoracic Surgery Database?  Please answer yes or no.

* 47. Number of years in practice after completion of residency?

* 48. Your approximate number of major general thoracic surgery operations last year....

Please rate how well this meeting facilitated your ability to meet the objectives of this program:
Please rate the quality of the following:

* 49. Lecturers and panel discussions

* 50. Presentation of new/timely information

* 51. Moderators

* 52. Program format

* 53. Overall quality of the speakers

* 54. Knowledge and helpfulness of GTSC staff

Commercial bias is defined as information presented in a certified educational activity that attempts to sway participant opinion in favor of commercial product/device, furthering a commercial entity's business initiatives.  Using this definition, please answer the following questions:

* 55. The therapeutic recommendations presented in this activity did not encourage inappropriate or excessive use of products/devices.

* 56. The information presented in this activity did not serve to advance a proprietary interest of any commercial entity.

* 57. As a result of participating in this activity, did you learn anything that would cause you to make a change in your office or practice?

* 58. If yes, how soon do you intend to incorporate these changes?

* 59. If no, please explain:

* 60. Suggestions for future topics: